Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review

Detalhes bibliográficos
Autor(a) principal: Nascimento, Lucas Cerqueira Gomes Barbosa do
Data de Publicação: 2022
Outros Autores: Alves Junior, Gledson Lima, Pereira, Vitor Moura, Rodrigues , Gerlan da Silva, Silva Júnior, Adriano Bezerra da, Lemos, André Luís Conceição, Santos, Rafael Valença de Souza, Nascimento, Adriel Barbosa do
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/34930
Resumo: Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents.
id UNIFEI_ce80ed55c7c06ed2d13d74bdeafc63fc
oai_identifier_str oai:ojs.pkp.sfu.ca:article/34930
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review Resistencia bacteriana en el tratamiento de la neumonía en pacientes hospitalizados: una revisión sistemática Resistência bacteriana no tratamento de pneumonia em pacientes de unidades hospitalares: uma revisão sistemática PneumoniaFarmacorresistência bacterianaAntibacterianos.Bacterial drug resistancePneumoniaAntibacterial.NeumoníaFarmacorresistencia bacterianaAntibacteriano.Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents.Objetivo: identificar las principales bacterias resistentes a fármacos amplios asociados al desarrollo de neumonía en pacientes hospitalarios de 2017 a 2022 a nivel mundial, comparando los agentes identificados antes y durante la pandemia por COVID-19. Metodología: Los artículos fueron buscados en las bases de datos Scielo, PubMed y UpToDate, siguiendo las pautas del Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). La estrategia ‘’PVOS’’ (population, variables, outcomes and study) se utilizó para seleccionar los artículos analizados en la revisión. Se utilizaron los descriptores estandarizados por los “Descritores em Ciências da Saúde’’: neumonía, antibacterianos, farmacorresistencia bacteriana, farmacorresistencia bacteriana múltiple para la encuesta bibliográfica. Incluidos en esta revisión sistemática, estudios observacionales analíticos, artículos de investigaciones publicadas, estudios de casos, revisiones sistemáticas y estudios epidemiológicos, microbiológicos y de vigilancia molecular. Resultados: Después del proceso de selección, la eliminación de artículos duplicados y el análisis de los criterios de inclusión, se identificaron 27 artículos como elegibles para esta revisión sistemática. Conclusión: Los resultados de esta revisión sistemática proporcionan evidencia de las principales bacterias causantes de neumonía en pacientes hospitalizados a nivel mundial, así como el perfil de resistencia en el caso de organismos multirresistentes, además de identificar alternativas de tratamiento para estos agentes.Objetivo: identificar quais são as principais bactérias resistentes a amplos medicamentos associadas ao desenvolvimento de pneumonia em pacientes de unidades hospitalares no período de 2017 a 2022 a nível mundial, comparando os agentes identificados antes e durante a pandemia devido a COVID-19. Metodologia: A pesquisa dos artigos foi realizada nas bases de dados Scielo, PubMed e UpToDate, sendo utilizadas as normas do Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). A estratégia ‘’PVOS’’ (population, variables, outcomes and study) foi utilizada para selecionar os artigos analisados na revisão. Foram utilizados os descritores padronizados pelos ‘’Descritores em Ciências da Saúde’’: pneumonia, antibacterianos, farmacorresistência bacteriana, farmacorresistência bacteriana múltipla para o levantamento bibliográfico. Foram incluídos nessa revisão sistemática estudos observacionais analíticos, artigos de pesquisa publicados, estudos de caso, revisões sistemáticas e estudos de vigilância epidemiológica, microbiológica, e molecular. Resultados: Após o processo de triagem, remoção de artigos duplicados e análises dos critérios de inclusão, 27 artigos foram identificados como elegíveis para esta revisão sistemática. Conclusão: Os resultados desta revisão sistemática fornecem evidências das principais bactérias causadoras de pneumonia em pacientes hospitalizados a nível mundial, bem como o perfil de resistência em caso de organismos multirresistentes, além de identificar alternativas de tratamento para esses agentes.Research, Society and Development2022-09-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3493010.33448/rsd-v11i13.34930Research, Society and Development; Vol. 11 No. 13; e25111334930Research, Society and Development; Vol. 11 Núm. 13; e25111334930Research, Society and Development; v. 11 n. 13; e251113349302525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/34930/29438Copyright (c) 2022 Lucas Cerqueira Gomes Barbosa do Nascimento; Gledson Lima Alves Junior; Vitor Moura Pereira; Gerlan da Silva Rodrigues ; Adriano Bezerra da Silva Júnior; André Luís Conceição Lemos; Rafael Valença de Souza Santos; Adriel Barbosa do Nascimentohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Nascimento, Lucas Cerqueira Gomes Barbosa doAlves Junior, Gledson LimaPereira, Vitor MouraRodrigues , Gerlan da Silva Silva Júnior, Adriano Bezerra da Lemos, André Luís Conceição Santos, Rafael Valença de Souza Nascimento, Adriel Barbosa do 2022-10-17T13:43:46Zoai:ojs.pkp.sfu.ca:article/34930Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:01.902646Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
Resistencia bacteriana en el tratamiento de la neumonía en pacientes hospitalizados: una revisión sistemática
Resistência bacteriana no tratamento de pneumonia em pacientes de unidades hospitalares: uma revisão sistemática
title Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
spellingShingle Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
Nascimento, Lucas Cerqueira Gomes Barbosa do
Pneumonia
Farmacorresistência bacteriana
Antibacterianos.
Bacterial drug resistance
Pneumonia
Antibacterial.
Neumonía
Farmacorresistencia bacteriana
Antibacteriano.
title_short Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
title_full Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
title_fullStr Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
title_full_unstemmed Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
title_sort Bacterial resistance in the treatment of pneumonia in hospital patients: a systematic review
author Nascimento, Lucas Cerqueira Gomes Barbosa do
author_facet Nascimento, Lucas Cerqueira Gomes Barbosa do
Alves Junior, Gledson Lima
Pereira, Vitor Moura
Rodrigues , Gerlan da Silva
Silva Júnior, Adriano Bezerra da
Lemos, André Luís Conceição
Santos, Rafael Valença de Souza
Nascimento, Adriel Barbosa do
author_role author
author2 Alves Junior, Gledson Lima
Pereira, Vitor Moura
Rodrigues , Gerlan da Silva
Silva Júnior, Adriano Bezerra da
Lemos, André Luís Conceição
Santos, Rafael Valença de Souza
Nascimento, Adriel Barbosa do
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Nascimento, Lucas Cerqueira Gomes Barbosa do
Alves Junior, Gledson Lima
Pereira, Vitor Moura
Rodrigues , Gerlan da Silva
Silva Júnior, Adriano Bezerra da
Lemos, André Luís Conceição
Santos, Rafael Valença de Souza
Nascimento, Adriel Barbosa do
dc.subject.por.fl_str_mv Pneumonia
Farmacorresistência bacteriana
Antibacterianos.
Bacterial drug resistance
Pneumonia
Antibacterial.
Neumonía
Farmacorresistencia bacteriana
Antibacteriano.
topic Pneumonia
Farmacorresistência bacteriana
Antibacterianos.
Bacterial drug resistance
Pneumonia
Antibacterial.
Neumonía
Farmacorresistencia bacteriana
Antibacteriano.
description Objective: identify the main bacteria resistant to broad drugs associated with the development of pneumonia in hospital patients from 2017 to 2022 worldwide, comparing the agents identified before and during the pandemic due to COVID-19. Methodology: The articles were searched in the Scielo, PubMed and UpToDate databases following the guidelines of the Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). The ‘’PVOS’’ strategy (population, variables, outcomes and study) was used to select the articles analyzed in the review. The descriptors standardized by the ‘’Descritores em Ciências da Saúde’’ were used: pneumonia, antibacterials, bacterial drug resistance, bacterial multiple drug resistance for bibliographic survey. Included in this systematic review, analytical observational studies, articles of published research, case studies, systematic reviews and epidemiological, microbiological, and molecular surveillance studies. Results: After the screening process, removal of duplicate articles and analysis of inclusion criteria, 27 articles were identified as eligible for this systematic review. Conclusion: The results of this systematic review provide evidence of the main bacteria causing pneumonia in hospitalized patients worldwide, as well as the resistance profile in the case of multidrug-resistant organisms, in addition to identifying treatment alternatives for these agents.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-26
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/34930
10.33448/rsd-v11i13.34930
url https://rsdjournal.org/index.php/rsd/article/view/34930
identifier_str_mv 10.33448/rsd-v11i13.34930
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/34930/29438
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 13; e25111334930
Research, Society and Development; Vol. 11 Núm. 13; e25111334930
Research, Society and Development; v. 11 n. 13; e25111334930
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052772071243776